Literature DB >> 9546955

Development of vascular complications in diabetes.

D E McMillan1.   

Abstract

Chronic complications of diabetes are dominated by disorders of the vascular system. They are a much larger burden on both diabetic patients and overall medical costs than diabetes itself. Large vessel problems are far more frequent than microvascular disorders. Loss of arterial elasticity alters arterial flow patterns and increases microcirculatory peak flow rates. Hyperglycemia may directly disrupt elastin formation. Diabetic leg artery disease may be generated by nerve damage, reversing this interactive contribution sequence. The major anatomic feature of microangiopathy in long-term diabetes is an unevenly distributed thickening of the intima of smaller arterioles. The thickening is primarily due to accumulation of type IV (basement membrane) collagen. Arterioles change local vessel diameter to adjust blood distribution to meet current needs. The thickening compromises the maximum local blood flow that may be achieved by this means. Compromise of maximal arteriolar dilatation does not disrupt exercising muscle but in the kidney, retina, and possibly in nerve, local circumstances can generate serious damage. Each of these system's responses has unique features that mediate its vulnerability, but all these organs show arteriolar hyalinization. The increased arteriolar accumulation of type IV collagen appears to be a response to the tangential force generated by flow over local endothelial cells. An increase in peak arteriolar wall force is mediated by a diabetes-specific doubling of erythrocyte membrane curvature change resistance. Red cell aggregation rate determines the rate of damage. The same nonspecific burden may also predispose to heart disease and stroke. Intensive metabolic control improves red cell deformability and protects against arteriolar damage. Therapies that address the rheologic problem more directly may add to the effectiveness of good diabetes control in the future.

Entities:  

Mesh:

Year:  1997        PMID: 9546955     DOI: 10.1177/1358863X9700200209

Source DB:  PubMed          Journal:  Vasc Med        ISSN: 1358-863X            Impact factor:   3.239


  7 in total

1.  The effects of repetitive vibration on sensorineural function: biomarkers of sensorineural injury in an animal model of metabolic syndrome.

Authors:  Megan Kiedrowski; Stacey Waugh; Roger Miller; Claud Johnson; Kristine Krajnak
Journal:  Brain Res       Date:  2015-10-01       Impact factor: 3.252

2.  Imaging rhodopsin degeneration in vivo in a new model of ocular ischemia in living mice.

Authors:  Jiaqian Ren; Yinching I Chen; Ashley M Mackey; Philip K Liu
Journal:  FASEB J       Date:  2015-10-06       Impact factor: 5.191

Review 3.  Disturbance of inorganic phosphate metabolism in diabetes mellitus: its relevance to the pathogenesis of diabetic retinopathy.

Authors:  H Vorum; J Ditzel
Journal:  J Ophthalmol       Date:  2014-03-20       Impact factor: 1.909

Review 4.  Diabetic retinopathy: could the alpha-1 antitrypsin be a therapeutic option?

Authors:  Gustavo Ortiz; Juan P Salica; Eduardo H Chuluyan; Juan E Gallo
Journal:  Biol Res       Date:  2014-11-18       Impact factor: 5.612

Review 5.  Angio-LncRs: LncRNAs that regulate angiogenesis and vascular disease.

Authors:  Bo Yu; Shusheng Wang
Journal:  Theranostics       Date:  2018-06-08       Impact factor: 11.556

6.  Prescribing pattern of drugs for cardiovascular co-morbidities in type 2 diabetes mellitus in a tertiary care Indian hospital.

Authors:  Dakshinamurthy Nishanthini; Balan Aravinda Kumar; Chandrashekaran Girish; Sadasivam Balakrishnan
Journal:  J Pharmacol Pharmacother       Date:  2014-01

7.  Differences of Retinal Blood Flow Between Arteries and Veins Determined by Laser Speckle Flowgraphy in Healthy Subjects.

Authors:  Takeshi Iwase; Eimei Ra; Kentaro Yamamoto; Hiroki Kaneko; Yasuki Ito; Hiroko Terasaki
Journal:  Medicine (Baltimore)       Date:  2015-08       Impact factor: 1.817

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.